|
See related Albumin-GCC inj information |
|
|
|
Manufacturer |
Green Cross Corp |
|
Distributor |
S Charoen Bhaesaj |
|
Contents |
Human serum albumin 20% |
|
Indications |
Prevention or treatment of hypovolemic syndrome & the aversion of CV collapse. Emergency treatment of shock. Burns. Hypoproteinemia & edema. Neonatal hyperbilirubinemia. |
|
Dosage |
Adult Initially 100 mL. Childn ¼-½ adult dose. To be given IV. |
|
Contraindications |
Severe anemia or cardiac failure in the presence of normal or increased intravascular vol. |
|
Special Precautions |
Patients w/ low cardiac reserve. |
|
Adverse Drug Reactions |
Rash, nausea, vomiting, tachycardia, hypotension, chill, fever.
View ADR Monitoring Form |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Albumin-GCC injection |
|
|
|
Manufacturer: |
Green Cross Corp |
|
Distributor: |
S Charoen Bhaesaj
|
|
|
|
